Braesel Jana, Eustáquio Alessandra S
Department of Medicinal Chemistry and Pharmacognosy and Center for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago, 900 South Ashland Ave, Chicago, IL 60607, USA.
J Braz Chem Soc. 2019 Mar;30(3):499-508. doi: 10.21577/0103-5053.20180234.
Genome mining provides exciting opportunities for the discovery of natural products. However, in contrast to traditional bioassay-guided approaches, challenges of genome mining include poor or no expression of biosynthetic gene clusters (BGCs). Additionally, given that thousands of BGCs are now available through extensive genome sequencing, how does one select BGCs for discovery? Synthetic biology techniques can be used for BGC refactoring and activation, whereas resistance-gene-directed genome mining is a promising approach to discover bioactive natural products. Here we report the selection of a BGC by applying a resistance-gene-directed approach, cloning of the silent BGC from sp. B006, promoter exchange, and heterologous expression in M1152. While we have yet to identify the encoded compound, we unexpectedly observed induction of a host metabolite, which we hypothesize is due to the presence of a ClpC chaperone gene in the BGC, suggesting that ClpC chaperones may be used for BGC activation.
基因组挖掘为天然产物的发现提供了令人兴奋的机会。然而,与传统的生物测定引导方法相比,基因组挖掘面临的挑战包括生物合成基因簇(BGC)表达不佳或不表达。此外,鉴于现在通过广泛的基因组测序可获得数千个BGC,如何选择用于发现的BGC呢?合成生物学技术可用于BGC重构和激活,而抗性基因导向的基因组挖掘是发现生物活性天然产物的一种有前途的方法。在此,我们报告了通过应用抗性基因导向方法选择一个BGC,从sp. B006中克隆沉默的BGC,进行启动子交换,并在M1152中进行异源表达。虽然我们尚未鉴定出编码的化合物,但我们意外地观察到一种宿主代谢物的诱导,我们推测这是由于BGC中存在一个ClpC伴侣基因,这表明ClpC伴侣蛋白可用于BGC激活。